Cepheid launches MRSA/SA tests in Europe:
This article was originally published in Clinica
Executive Summary
Cepheid has launched onto the European market two rapid tests for detecting methicillin-resistant staphylococcus aureus (MRSA) and staphylococcus aureus (SA). The tests are: Xpert MRSA/SA-blood cultures (BC), and Xpert MRSA/SA-skin and soft tissue infection (SSTI). They take just 50 minutes to deliver results, potentially allowing better patient management for those affected, said the firm. MRSA and SA are on the rise as two of the leading causes of hospital- and community-acquired infections, claimed the Sunnyvale, California company.